OncoTherapy Science, Inc. (TYO:4564)
Japan · Delayed Price · Currency is JPY 20.00
0.00 (0.00%)
At close: Feb 6, 2026
OncoTherapy Science Market Cap
OncoTherapy Science has a market cap or net worth of 7.53 billion as of February 6, 2026. Its market cap has increased by 15.54% in one year.
Market Cap
7.53B
Enterprise Value
5.86B
Revenue
956.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.00
Market Cap Chart
Since June 29, 2007, OncoTherapy Science's market cap has decreased from 13.84B to 7.53B, a decrease of -45.58%. That is a compound annual growth rate of -3.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 7.53B | 9.60% |
| Dec 30, 2025 | 6.87B | 1.20% |
| Dec 30, 2024 | 6.79B | 35.66% |
| Dec 29, 2023 | 5.01B | -50.03% |
| Dec 30, 2022 | 10.02B | -27.78% |
| Dec 30, 2021 | 13.87B | -31.60% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| StemCell Institute | 8.53B |
| BrightPath Biotherapeutics | 8.02B |
| CellSource | 7.97B |
| K Pharma,Inc. | 7.95B |
| MEDINET | 7.94B |
| ADR120S | 7.79B |
| Chiome Bioscience | 7.73B |
| PRISM BioLab Co.,LTD | 7.05B |